All values were normalized to fully oxidized (AT-2-treated) and fully reduced (DTT-treated) roGFP2 with the following equation [1]: with R ox being the 405/488 ratio of oxidized (AT2-treated) and R red of reduced (DTT-treated) roGFP2 respectively
Inhibition of DPP-IV activity in wild-type mice by pharmacological agents results in improvement in glucose tolerance, whereas this effect has not been observed in DPP-IV knockout mice (Marguet et al
Gondo et al, Growth Hormone-Releasing Peptide-2 Stimulates GH Secretion in GH-Deficient Patients with Mutated GH-Releasing Hormone Receptor, The Journal of Clinical Endocrinology & Metabolism, Volume 86, Issue 7, 1 July 2001, Pages 32793283, Mericq V, Cassorla F, Salazar T, Avila A, Iiguez G, Bowers CY, Merriam GR
Thyroid Function Tests (TFTs): Rule out thyroid-related contributors to metabolic dysfunction